Pulike Biological Engineering (603566) — Cash Flow Quality Index
Pulike Biological Engineering (603566) has a Cash Flow Quality Index of 2.13x as of September 2025. Operating cash flow of CN¥87.38 Million exceeds net income of CN¥40.95 Million, indicating high earnings quality where cash backs reported profits. Explore Pulike Biological Engineering strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pulike Biological Engineering Cash Flow Quality Index (2012–2024)
Historical Cash Flow Quality Index for Pulike Biological Engineering across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 603566 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Pulike Biological Engineering (2012–2024)
Year-by-year earnings quality comparison for Pulike Biological Engineering. For live market cap and the full company financial profile, see 603566 market cap.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.90x | CN¥268.79 Million | CN¥92.81 Million | ▲ +78.7% |
| 2023 | 1.62x | CN¥282.78 Million | CN¥174.52 Million | ▲ +19.1% |
| 2022 | 1.36x | CN¥228.36 Million | CN¥167.82 Million | ▲ +56.3% |
| 2021 | 0.87x | CN¥212.53 Million | CN¥244.14 Million | ▼ -24.3% |
| 2020 | 1.15x | CN¥261.83 Million | CN¥227.74 Million | ▼ -10.4% |
| 2019 | 1.28x | CN¥140.10 Million | CN¥109.25 Million | ▲ +37.7% |
| 2018 | 0.93x | CN¥126.27 Million | CN¥135.61 Million | ▼ -24.5% |
| 2017 | 1.23x | CN¥140.86 Million | CN¥114.19 Million | ▼ -8.3% |
| 2016 | 1.35x | CN¥253.03 Million | CN¥188.00 Million | ▲ +2.0% |
| 2015 | 1.32x | CN¥187.09 Million | CN¥141.74 Million | ▲ +22.4% |
| 2014 | 1.08x | CN¥151.21 Million | CN¥140.26 Million | ▼ -3.1% |
| 2013 | 1.11x | CN¥181.21 Million | CN¥162.86 Million | ▼ -2.8% |
| 2012 | 1.15x | CN¥147.96 Million | CN¥129.21 Million | — |